View Information Collection (IC) List View Supporting Statement and Other Documents
Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.


View ICR - OIRA Conclusion



3150-0010 200103-3150-003
Historical Active 199912-3150-004
NRC
10 CFR Part 35, Medical Use of Byproduct Material
Revision of a currently approved collection   No
Regular
Approved without change 09/18/2001
03/14/2001
This information collection is approved under 5 CFR 1320. When submitting a request to revise or extend this collection, the NRC should ensure the following: I) That each of the record-keeping and reporting requirements contained in 10 CFR 35 have practical utility, as required by 5 CFR 1320.5 (d)(1)(iii). In determining whether these requirements have practical utility, the NRC should consider any new information regarding: a) the risks posed by the medical use of reactor byproduct materials, b) the burden imposed by the information collection requirements, c) and the costs and efficacy of alternative strategies for assuring safe use of these materials--including reliance on existing professional standards and state and federal medical and pharmaceutical laws. II) That requirements for record-keeping and reporting are the least burdensome necessary, as is required by 5 CFR 1320.5(d)(1) (i). In ensuring that its approach is the least burdensome necessary, the NRC should consider: a) whether alernatives, including the use of a third-party accrediting organization, would achieve the same purpose in a less burdensome way, b) whether records and reports related to the radiation safety program and its management would be sufficient to ensure safety without requiring retention of program records and written procedures, c) and whether the retention period for records can be shortened without damaging the NRC's ability to fulfill its purpose in these regulations. III) That the reporting threshold for a "medical event" ensures that all such reports have practical utility. The NRC should examine any new information regarding the risks posed by variation from the prescribed doses and examine whether a different threshold would better satisfy the requirements that information collected have practical utility (5 CFR 1320.5 (d)(1) (iii)) and is the least burdensome necessary (5 CFR 1320.5 (d)(1) (i)). In making the above determinations, the NRC should consult with licensees or relevant stakeholders, as well as with agreement states responsible for regulating the medical use of reactor byproduct materials.
  Inventory as of this Action Requested Previously Approved
09/30/2004 09/30/2004 10/31/2002
214,402 0 6,676,254
889,754 0 1,294,681
16,000 0 0